Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy-Reference-Cited by-同舟云学术

Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy

Published:2011-04 Issue:4 Volume:54 Page:604-611
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Oze Tsugiko,Hiramatsu Naoki,Yakushijin Takayuki,Mochizuki Kiyoshi,Oshita Masahide,Hagiwara Hideki,Mita Eiji,Ito Toshifumi,Fukui Hiroyuki,Inui Yoshiaki,Hijioka Taizo,Inada Masami,Kaytayama Kazuhiro,Tamura Shinji,Yoshihara Harumasa,Inoue Atsuo,Imai Yasuharu,Kato Michio,Miyagi Takuya,Yoshida Yuichi,Tatsumi Tomohide,Kiso Shinichi,Kanto Tatsuya,Kasahara Akinori,Takehara Tetsuo,Hayashi Norio

Funder

Ministry of Health Labour and Welfare of Japan

Scientific Research from the Ministry of Education, Science, and Culture of Japan

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

2. Antiviral therapy for chronic hepatitis C: past, present, and future;Hayashi;J Gastroenterol,2006

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

5. The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr;Antonucci;Am J Gastroenterol,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment;Life;2023-09-26

2. Characteristics of patients aged over 75 years with hepatitis C virus infection treated with direct‐acting antivirals in Japan: Evidence based on the nationwide, real‐world database in Japan;Hepatology Research;2021-03

3. Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy;Journal of Medical Virology;2016-03-29

4. Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C;Clinical Interventions in Aging;2016-03

5. Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis;Current Infectious Disease Reports;2016-02-25